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Background: CREB (cAMP-response element binding protein) is the prototypical signal-regulated transcription
factor. In neurons, it is the target of the synaptic activity-induced nuclear calcium-calcium/calmodulin dependent
protein kinase (CaMK) IV signaling pathway that controls the expression of genes important for acquired
neuroprotection as well as other long-lasting adaptive processes in the nervous system. The function of CREB as a
transcriptional activator is controlled by its phosphorylation on serine 133, which can be catalyzed by CaMKIV and
leads to the recruitment of the co-activator, CREB binding protein (CBP). Activation of CBP function by nuclear
calcium-CaMKIV signaling is a second regulatory step required for CREB/CBP-mediated transcription.
Results: Here we used recombinant adeno-associated virus (rAAV) to increase the levels of wild type CREB or to
overexpress a mutant version of CREB (mCREB) containing a serine to alanine mutation at position amino acid 133
in mouse hippocampal neurons. Increasing the levels of CREB was sufficient to boost neuroprotective activity even
under basal conditions (i.e., in the absence of stimulation of synaptic activity). In contrast, overexpression of mCREB
increased cell death. The ratio of phospho(serine 133)CREB to CREB immunoreactivity in unstimulated hippocampal
neurons was similar for endogenous CREB and overexpressed wild type CREB and, as expected, dramatically
reduced for overexpressed mCREB. A gene expression analysis revealed that increased expression of CREB but not
that of mCREB in hippocampal neurons led to elevated expression levels of bdnf as well as that of several members
of a previously characterized set of Activity-regulated Inhibitor of Death (AID) genes, which include atf3, btg2,
gadd45β, and gadd45γ.
Conclusions: Our findings indicate that the expression levels of wild type CREB are a critical determinant of the
ability of hippocampal neurons to survive harmful conditions. Increasing the levels of wild type CREB can, even
without inducing synaptic activity, increase pro-survival gene expression and strengthen the neurons’
neuroprotective shield. The observed degradation of CREB protein following NMDA treatment of hippocampal
neurons suggests that the known CREB shut-off associated with extrasynaptic NMDA receptor-induced
excitotoxicity is followed by CREB proteolysis.
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Figure 1 Immunocytochemical (A) and immunoblot analyses
(B) of hippocampal neurons infected with rAAVs containing
expression cassettes for hrGFP, CREB or mCREB. CREB and
mCREB contain triple Flag epitope tags and were detected with
M2 Flag antibody; hrGFP was detected with an antibody to
hrGFP. Cell nuclei were counterstained with Hoechst 33258.
Representative images are shown. Scale bar, 10 μm.
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In neurons, the transcription factor CREB and its co-ac-
tivator CBP are central players in synaptic activity-driven
gene transcription that contributes to the process
through which neurons convert signals from the envir-
onment into genomic responses required for long-lasting
adaptations [1-3]. Acquired neuroprotection is a well-
studied adaptive response in which neurons that have
undergone periods of synaptic activity are rendered
more resistant to harmful conditions [2,4-11]. This built-
up of a neuroprotective shield is initiated by calcium
entry though synaptic NMDA receptors and requires
calcium transient invading the cell nucleus [8-12]. Nu-
clear calcium acting principally via nuclear CaMKIV
leads to phosphorylation of CREB on its activator site
serine 133, allowing CREB to form a complex with CBP
[13]. The second regulatory step required for induction
of CREB/CBP-mediated transcription is the activation of
CBP function by nuclear calcium-CaMKIV signaling [14-
16]. Transcriptome analyses have identified a set of neu-
roprotective genes that are induced by synaptic activity
and controlled by nuclear calcium signaling [9,10]. Sev-
eral members of this group of genes, which were termed
Activity-regulated Inhibitor of Death (AID) genes, are
known or putative CREB target genes [10,11]. In
addition to the ability of CREB to mediate the process
that leads to ‘added-on’ survival activity upon synaptic
stimulation, the presence of CREB seems to be required
for the health of the neurons even under conditions of
basal synaptic activity. Mice that lack CREB (and its
close relative cAMP response element modulator,
CREM) exhibit widespread cell death in the brain [17],
and the reduction of functional CREB by means of ex-
pression of inhibitors of CREB can severely compromise
the well being of neuron [18-20]. Given that physio-
logical expression levels of functional CREB appear to be
required cell survival we reasoned that increasing the
levels of CREB in hippocampal neurons may enhance
neuroprotection even under basal conditions. Here we
have tested this hypothesis and found that indeed over-
expression of wild type CREB, even without inducing
synaptic activity, increases the expression of several AID
genes and renders hippocampal neurons more resistant
to cell death inducing conditions. Consistent with the
importance of having physiological levels of functional
CREB available at promoter regions for the maintenance
of cell vitality, expression of mCREB increased cell
death.
Results and discussion
Expression and serine 133 phosphorylation of wild type
and mutant CREB
To investigate the relationship between cellular CREB
levels and neuronal survival activity, we infected primarymouse hippocampal neurons with a recombinant adeno-
associated virus containing an expression cassette for
wild type rat CREB, a mutant version of CREB (mCREB)
containing a serine to alanine mutation at position
amino acid 133, or hrGFP (humanized Renilla reniformis
green fluorescent protein). Expression of all three pro-
teins following infection of mouse hippocampal neurons
with rAAV-CREB, rAAV-mCREB, or rAAV-hrGFP was
readily detectable immunocytochemically or GFP fluor-
escence in 80 to 95% of the viable cells (Figure 1A). The
correct size proteins were also detected in immunoblots
(Figure 1B; note that due to the fusion of the exogen-
ously expressed CREB and mCREB to a triple Flag tag,
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is slightly larger than that of the endogenous CREB).
Analysis of the phosphorylation of CREB on serine
133 in unstimulated hippocampal neurons using phos-
pho(serine133)CREB-specific antibodies revealed very
weak signals for the endogenous CREB protein in all
samples analyzed (Figure 2A). We detected muchFigure 2 (A) Immunoblot analysis of expression and
phosphorylation on serine 133 of endogenous and
overexpressed CREB in uninfected hippocampal neurons and in
neurons infected with rAAV-hrGFP, rAAV-CREB and rAAV-
mCREB. CREB expression and CREB phosphorylation on serine
133 (pCREB) was assessed using antibodies to CREB and
antibodies specific for the serine 133 phosphorylated form of
CREB, respectively. (B) Quantitative analysis of the levels of CREB
and CREB phosphorylated on serine 133 (pCREB). In uninfected
hippocampal neurons and in neurons infected with rAAV-hrGFP, the
ratio of pCREB to CREB (pCREB/CREB) was calculated for
endogenous CREB; for hippocampal neurons infected with rAAV-
CREB and rAAV-mCREB, the ratios were determined for
overexpressed CREB and mCREB. Bars represent means ± SEM (n = 3).
Statistical significance was determined by One-way ANOVA,
Bonferroni post hoc test; statistically significant differences are
indicated with an asterisk (***p< 0.001 versus rAAV-hrGFP; N.S., not
significant).stronger phospho(serine133)CREB immunoreactivity for
the overexpressed CREB protein, while, as expected, low
levels of phospho(serine133)CREB immunoreactivity
were obtained for mCREB. The ratio of phospho
(serine133)CREB to CREB immunoreactivity was similar
for the endogenous CREB and the overexpressed wild
type CREB, but, in contrast, was dramatically reduced
for overexpressed mCREB (Figure 2B). This suggests
that the strong phospho(serine133)CREB signal obtained
using lysates from hippocampal neurons infected with
rAAV-CREB reflects the large amount of CREB protein
present in the cells, which compared to the endogenous
CREB appears to contain a similar fraction of the serine
133-phosphorylated form. However, we cannot rule out
the possibility that the phospho(serine133)CREB-specific
antibody solution contains a small fraction of antibodies
that bind to CREB even when it is not phosphorylated
on serine 133. In this scenario, the phospho(serine133)
CREB immunoreactivity detected in samples from
rAAV-CREB infected neurons may not indicate the pres-
ence of a subset of serine133-phosphorylated CREB
molecules but it is merely the result of the binding to
CREB of the fraction of the antibody solution that can
interact with the non-phosphorylated epitope. The ob-
servation that mCREB yielded a very weak signal with
the phospho(serine133)CREB-specific antibody solution
does not argue against this possibility because the muta-
tion of serine 133 not only abolished any possible phos-
phorylation event at amino acid 133 but may also alter
the epitope thereby reducing the binding to CREB of
those antibodies (within the solution of the phospho
(serine133)CREB-specific antibodies) that recognize
CREB not phosphorylated on serine 133. The antibody
used to detect total CREB levels was generated using a
recombinant N-terminal fragment of CREB as an
antigen.
Elevated CREB level protects against apoptosis and
excitotoxicity
In order to investigate a possible neuroprotective effect
of elevating intracellular CREB levels, hippocampal neu-
rons were infected with rAAV-mCREB, rAAV-CREB,
rAAV-hrGFP on day in vitro (DIV) 4. Six days post-
infection, the neurons were challenged using three dif-
ferent types of cell death-inducing conditions. We trea-
ted neurons with a low concentration of staurosporine
and growth factor withdrawal to induce apoptosis, and
bath application of 20 μM NMDA to trigger excitotoxi-
city [10,11]. We found that in all three types of cell death
assays, the stimulus-induced increase in the percentage
of dead neurons was smaller in hippocampal cultures
infected with rAAV-CREB compared to the uninfected or
rAAV-hrGFP infected control (Figure 3A-D). This indi-
cates that increasing the levels of CREB in hippocampal
Figure 3 Increasing levels of CREB protects against apoptosis and excitotoxicity. (A) Analysis of cell death in uninfected hippocampal
neurons and in hippocampal neurons infected with rAAVs-hrGFP, rAAV-CREB or rAAV-mCREB. CREB and mCREB were detected with the
M2 Flag antibody; hrGFP was detected with an antibody to hrGFP. Cell death was determined by analyzing Hoechst stained nuclei with shrunken
cell body and large round chromatin clumps. For mCREB expression we obtained very weak Flag immunoreactivity in the death-inducing
conditions, which is most likely due to compromised cell health following mCREB expression. Representative images are shown. Scale bar, 10 μm.
Quantitative analysis of cell death induced by 10 nM staurosporine (B), growth factor withdrawal (C), or bath application of 20 μM NMDA (D).
Bars represent means ± SEM (n = 4). Statistical significance was determined by Two-way ANOVA, Bonferroni post hoc test; statistically significant
differences are indicated (***p< 0.001, **p< 0.01, *p< 0.05 compared to rAAV-hrGFP infected neurons in groups induced to undergo cell death;
###p< 0.001, ##p< 0.01 compared to rAAV-hrGFP infected neurons in untreated groups).
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excitotoxicity. In contrast, overexpression of mCREB
failed to provide neuroprotection and, instead, increased
the basal death rates (Figure 3A-D). Because mCREB can
bind to the CRE [21], it competes with endogenous
CREB for docking sites within gene regulatory regions.
This may explain the cell death-promoting activity of
mCREB, consistent with the hypothesis that a reduction
below physiological levels of functional CREB available at
target gene promoters renders neurons more susceptible
for harmful conditions.
NMDA-induced CREB phosphorylation, CREB shut-off, and
CREB degradation
Increasing the levels of CREB expression in hippocampal
neurons did not change the dynamics of CREB phos-
phorylation on serine 133 after exposure to 20 μM
NMDA. We found that the ratio of phospho(serine133)
CREB immunoreactivity (pCREB) to CREB immunoreac-
tivity increased very transiently after stimulation in unin-
fected hippocampal neurons and in neurons infected
with rAAV-CREB and rAAV-hrGFP (Figure 4A, B). Peak
levels of the pCREB/CREB immunoreactivities for both
endogenously and exogenously expressed CREB were
observed at 2 min after stimulation, which is followed by
a rapid shut-off of CREB phosphorylation on serine 133
(Figure 4A, B). Because we observed significant degrad-
ation of CREB at 60 min after NMDA treatment
(Figure 4A), a meaningful ratio of pCREB to CREB
immunoreactivities cannot be determined for this time
point. The degradation of CREB protein after induction
of excitotoxicity, which is already detectable 30 min
after exposure to NMDA, appears to start within the
amino-terminus of CREB because degradation products
of exogenously expressed CREB, Flag-tagged at the carb-
oxyl-terminus, are detected with antibodies to Flag but
not with antibodies to CREB that recognize an amino-
terminal epitope (Figure 4A, CREB degradation products
are indicated by an asterisk). It is tempting to speculate
that CREB degradation, which may be catalyzed by the
calcium dependent protease, calpain, is causally involved
in the cell death process. Thus, excitotoxicity triggered
by the stimulation of extrasynaptic NMDA receptors
leads in a first phase to a rapid CREB shut-off (i.e.,
dephosphorylation of phospho(serine133) of CREB) [7],
which is followed by the degradation of CREB protein.
Overexpression of CREB delays the excitotoxicity-asso-
ciated depletion of CREB from the neurons, which likely
contributes to neuroprotection.
CREB regulation of survival gene expression
In a previous study we have identified a set of synaptic ac-
tivity- and nuclear calcium-regulated neuroprotective
genes, which were termed Activity-regulated Inhibitor ofDeath (AID) genes [10] Several AID genes are known or
putative CREB target genes [10,11]. We therefore investi-
gated the possibility that the observed neuroprotection
following infection with rAAV-CREB is associated with an
increase in AID gene expression. Compared to uninfected
hippocampal neurons and neurons infected with rAAV-
hrGFP or rAAV-mCREB, we detected a 2- to 3- fold in-
crease in the expression of the AID genes, atf3, btg2,
gadd45β, and gadd45γ after 5 and/or 6 days post infection
(i.e., DIV 9 or DIV 10) with rAAV-CREB (Figure 5A, B).
We also observed a slight but significant increase in the
bdnf expression 5 days after infection with rAAV-CREB
(Figure 5A). These findings suggest that neuroprotection
afforded by elevated CREB levels may be the result of
increased expression of neuroprotective genes.
Conclusions
Our results indicate that increasing cellular CREB levels
can enhance the ability of hippocampal neurons to sur-
vive neurotoxic stimuli. This form of CREB-mediated
neuroprotection is being built up under conditions of
basal neuronal activity and is associated with an increase
of several survival promoting genes.
Methods
Hippocampal cell culture
Hippocampal neurons from newborn C57Black6 mice
were prepared as described previously [9,22,23]. Neurons
were plated onto either 12 mm glass coverslips or
35 mm dishes at a density between 400 and 600 cells per
mm2 and cultured in Neurobasal media (Invitrogen,
Gaithersburg, MD, USA) containing 1% rat serum and
B27 (Invitrogen), and penicillin and streptomycin
(Sigma). On days in vitro (DIV) 3, 2.4 μM cytosine D-
arabinofuranoside (Sigma) was added to each dish to
prevent proliferation of non-neuronal cells. At DIV 8,
medium was replaced with transfection medium (TM)
[22] which consists of a salt-glucose-glycine (SGG) solu-
tion and minimum Eagle’s medium (9:1; v/v) with so-
dium selenite 10 μg/ml, insulin 15 μg/ml, transferring
8.25 μg/ml, and penicillin-streptomycin 0.5%. SGG
includes (in mM): NaCl 114, NaHCO3 26, KCl 6.3,
MgCl2 1, CaCl2 2, Hepes 10, glycine 1, glucose 30, so-
dium pyruvate 0.5, Phenol Red 0.2%. All the experiments
were done after a culturing period of 10 to 13 days dur-
ing which hippocampal neurons develop a rich network
of processes, express function NMDA-type and AMPA/
kainite-type glutamate receptors, and form synaptic con-
tacts [7,24].
Recombinant adeno-associated viruses
The vectors used to construct and package rAAVs have
been described previously [9,10,25]. The recombinant
virus for the expression of the humanized Renilla
Figure 4 (A) Immunoblot analysis of expression and
phosphorylation on serine 133 of endogenous CREB (endo-
CREB; endo-pCREB) and overexpressed CREB (exo-CREB; exo-
pCREB) in uninfected hippocampal neurons and in neurons
infected with rAAV-hrGFP or rAAV-CREB at the indicated times
after treatment with 20 μM NMDA. Expression of endogenous
and overexpressed CREB was analyzed with an antibody to CREB;
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described in previous work [9]. A recombinant adeno-
associated virus vector containing 1 kbp cytomegalovirus
enhancer (CMV)/chicken β actin hybrid promoter
(CBA) was used to express CREB and mCREB. Both
rAAV-CREB and rAAV-mCREB contain triple FlagFigure 4
overexpressed CREB was also detected using an anti-Flag antibody.
CREB phosphorylation on serine 133 (pCREB) was assessed using
antibodies specific for the serine 133 phosphorylated form of CREB.
CREB degradation products are indicated by an asterisk. (B)
Quantitative analysis of the pCREB/CREB ratios of the immunoblot
analyses shown in (A). Means ± SEM are given (n = 4).epitope tag. All the vectors were generated by standard
molecular biology techniques and verified by sequencing.
Viral particles were produced and purified as described
previously [9,10,26,27]. For viral infection, neurons were
infected with 1011 rAAV particles/μL at DIV 4. Infection
efficiencies were determined immunocytochemically at
DIV 9 or 10 by using antibodies to the Flag tag, or by
analyzing the fluorescence of hrGFP; they ranged from
80%-95% of the viable neurons.
Immunocytochemistry
Mouse hippocampal neurons were fixed with 4% paraf-
ormaldehyde for 15 min and permeabilized with 0.3%
Triton X 100 in PBS for 10 min. PFA was blocked by 10
min incubation in 1.25 M Glycine. After washing in
PBS, the cells were blocked with blocking buffer (2%
BSA, 10% normal goat serum in PBS) at room
temperature for 1 h. The cells were exposed to primary
antibody (anti-Flag M2 Flag antibody, Sigma, MO, US)
in dilution buffer (2% BSA, 0.1% Triton X 100 in PBS) at
4°C overnight, washed in PBST (0.1% Tween 20 in PBS)
and exposed to secondary antibodies in dilution buffer.
After washing with PBST, the cells were incubated with
Hoechst 33258 for 5 min, washed in PBS and mounted
with mowiol and glycerol mounting medium, and dried
at room temperature overnight. The cells were examined
by fluorescent microscopy using a Leica SP2 confocal
microscope (Leica, Wetzlar, Germany).
Immunoblot analysis
Hippocampal neurons incubated under appropriate con-
ditions were washes with ice-cold PBS and cell lysates
were prepared. The lysates were mixed with 5 ×
Laemmli sample buffer and boiled for 5 min. The pro-
teins were resolved on 10% SDS-polyacrylamide gels and
transferred to nitrocellulose (NC) membranes. The blots
were blocked with Tris-buffered saline with Tween-20
(TBST; 20 mM Tris–HCl [PH 7.6], 0.136 M NaCl and
0.5% Tween-20 [vol./vol.]) containing 5% skim milk at
room temperature for 1 h followed by incubation of pri-
mary antibody in TBST containing 5.0% BSA at 4°C
Figure 5 QRT-PCR analysis of atf3, btg2, gadd45β, and gadd45γ and bdnf expression in uninfected hippocampal neurons and in
neurons infected with rAAV-hrGFP, rAAV-CREB and rAAV-mCREB. Gene expression analyses were done on DIV 9 (A) and DIV 10 (B), which
correspond to five days and six days, respectively, post-infection. Bars represent SEM (n= 3). Statistical significance was determined by One-way
ANOVA, Bonferroni post hoc test, statistically significant differences are indicated with an asterisk (***p< 0.001, **p< 0.01, *p< 0.05).
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(pCREB) were measured by immunoblotting using the
antibodies to the CREB (rabbit monoclonal antibody;
Cell Signaling Technology, MA, USA) and pCREB
(rabbit polyclonal antibody; Upstate, MA, USA); hrGFP
expression levels were detected using antibody to the
hrGFP (rabbit polyclonal antibody; Stratagene); tubulin
(mouse monoclonal antibody; Sigma, MO, US) waschosen as the loading control. After washing with TBST,
goat-anti-rabbit or mouse HRP conjugated IgG (Pro-
mega, WI, US) were added for 1 h at room temperature.
Blots were then washes with TBST and exposed to X-ray
film. The blots were quantitatively analyzed using ImageJ
(http://rsb.info.nih.gov/ij/). All results are given as means
± SEM; statistical significance was determined by One-
way ANOVA, Bonferroni post hoc test.
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To determine the mRNA levels of the potential pro-sur-
vival genes regulated by CREB, QRT-PCR was performed
using real-time TaqMan technology with a sequence de-
tection system model 7300 Real Time PCR System (Ap-
plied Biosystems, Foster City, CA, USA). Total RNA was
extracted using RNeasy kit (Qiagen GmbH, Germany)
with additional on-column DNase I digestion during RNA
purification. cDNA was generated from 1.5 μg of total
RNA using High Capacity cDNA Reverse Transcription
kit (Applied Biosystems). QRT-PCR was carried out using
TaqMan Universal PCR Master Mix (Applied Biosystems).
The following TaqMan gene expression assays were used
in this study: atf3 (Mm00476032), bdnf (Mm00432069),
btg2 (Mm00476162), gadd45β (Mm00435123), gadd45γ
(Mm00442225), gusb (Mm00446953_m1). The thermal
cycling conditions comprised 10 min at 95°C, and 45
cycles of 15 s for denaturation at 95°C and 60 s for anneal-
ing and extension at 60°C. The expression levels of the tar-
get mRNA were normalized to the relative ratio of the
expression of gusb mRNA. Each QRT-PCR assay was per-
formed three times. All results are given as means ± SEM;
statistical significance was determined by One-way
ANOVA, Bonferroni post hoc test.
Assessment of cell death
The induction and analysis of NMDA induced neuronal
cell death assay was done as described with slight
changes [11,27,28]. Briefly, the cells were treated with 20
μM NMDA for 10 min at 37°C, washed three times with
TM and incubated at 37°C for 20 h. The percentage of
dead cells was determined by analyzing Hoechst 33258
stained nuclei, and the percentage of dead cells was
determined. The Staurosporine induced and growth fac-
tor withdrawal induced apoptosis assay have been
described previously [9-11]. Briefly, 36 h after stauros-
porine (10 nM) exposure, or 72 h after keeping hippo-
campal neurons in TM medium minus the growth and
trophic factors, all in the presence of 1 μM tetrodotoxin
(TTX, Tocris Bioscience), cell death was assessed by de-
termining the percentage of hippocampal neurons with
shrunken cell body and large round chromatin clumps.
All the cell death assays were done at DIV 10-13, at least
20 visual fields from each coverslip (corresponding to
1500–2000 cells per coverslip) were counted. All results
are given as means ± SEM; statistical significance was
determined by Two-way ANOVA, Bonferroni post hoc
test.
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